AML 7+3 Induction Response Probability

Estimate complete remission probability from standard 7+3 induction (cytarabine x7 days + daunorubicin x3 days) based on age, ELN risk, secondary AML, and prior MDS/therapy.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate complete remission probability from standard 7+3 induction (cytarabine x7 days + daunorubicin x3 days) based on age, ELN risk, secondary AML, and prior MDS/therapy

Each component has a specific meaning:

  • Standard 7+3 induction based on age — The standard 7+3 induction based on age recorded for the scenario being assessed.
  • ELN risk — The eln risk recorded for the scenario being assessed.
  • Secondary AML — The secondary aml recorded for the scenario being assessed.
  • Prior MDS/therapy — The prior mds/therapy recorded for the scenario being assessed.

Note: Interpret the aml 7+3 response result against the thresholds and context described above.

How to Use

Enter the standard 7+3 induction based on age, ELN risk, secondary AML, prior MDS/therapy for the scenario you are assessing. Estimate complete remission probability from standard 7+3 induction (cytarabine x7 days + daunorubicin x3 days) based on age, ELN risk, secondary AML, and prior MDS/therapy. Use the aml 7+3 response result to inform your calculation.

Related Calculators

AML ELN 2022

Medical Long-tail

AML Blast Threshold

Medical Long-tail

Frequently Asked Questions